Nexthera Capital’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Nexthera Capital’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,026,906	Closed	-$21.5M	–	55
2018 Q3	$21.5M	Buy	1,026,906 +206,558	+25%	+$4.92M	4.13%	7
2018 Q2	$24.5M	Buy	820,348 +252,105	+44%	+$6.87M	3.8%	6
2018 Q1	$15.4M	Buy	568,243 +115,211	+25%	+$3.45M	2.54%	11
2017 Q4	$13M	Buy	453,032 +14,913	+3%	+$409K	2.41%	12
2017 Q3	$10.6M	Buy	438,119 +240,060	+121%	+$5.69M	2.74%	12
2017 Q2	$4.42M	Buy	+198,059	New	+$4.17M	1.92%	20

Other funds holding DOVA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fosun International Hong Kong, China $369M AUM 6.93% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nexthera Capital's DOVA Position: Q4 2018 in Review

Nexthera Capital sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2018, closing a stake of 1,026,906 shares — an estimated $21.5M sold.

Nexthera Capital first reported a position in DOVA in Q2 2017 and held it in 6 quarters. The position peaked at $24.5M in Q2 2018. 58 funds tracked by Wall St. Rank hold DOVA as of Q4 2018.

Nexthera Capital reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Nexthera Capital sold 1,026,906 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2018, an estimated $21.5M.
Nexthera Capital first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2017 and held it in 6 quarters.
Nexthera Capital's Dova Pharmaceuticals, Inc. Common Stock position peaked at $24.5M in Q2 2018.
58 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2018.

Based on Nexthera Capital's 13F filing for Q4 2018, filed 14 Feb 2019.